Mpo, CPTAC-3375 - CPTAC Assay Portal (original) (raw)
Please include the following statement when referencing the CPTAC Assay Portal
We would like to acknowledge the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay Portal (assays.cancer.gov) for developing assays and establishing criteria for the assays described in this publication.
Protein Sequence hover to view complete sequence
non-CPTAC-3375: View additional IANVFTNAFR data
10 | 20 | 30 | 40 | 50 |
---|---|---|---|---|
MKLLLALAGL | LAPLAMLQTS | NGATPALLGE | VENSVVLSCM | EEAKQLVDRA |
60 | 70 | 80 | 90 | 100 |
YKERRESIKR | SLQSGSASPT | ELLFYFKQPV | AGTRTAVRAA | DYLHVALDLL |
110 | 120 | 130 | 140 | 150 |
KRKLQPLWPR | PFNVTDVLTP | AQLNLLSVSS | GCAYQDVRVT | CPPNDKYRTI |
160 | 170 | 180 | 190 | 200 |
TGHCNNRRSP | TLGASNRAFV | RWLPAEYEDG | VSMPFGWTPG | VNRNGFKVPL |
210 | 220 | 230 | 240 | 250 |
ARQVSNAIVR | FPNDQLTKDQ | ERALMFMQWG | QFLDHDITLT | PEPATRFSFF |
260 | 270 | 280 | 290 | 300 |
TGLNCETSCL | QQPPCFPLKI | PPNDPRIKNQ | KDCIPFFRSC | PACTRNNITI |
310 | 320 | 330 | 340 | 350 |
RNQINALTSF | VDASGVYGSE | DPLARKLRNL | TNQLGLLAIN | TRFQDNGRAL |
360 | 370 | 380 | 390 | 400 |
MPFDSLHDDP | CLLTNRSARI | PCFLAGDMRS | SEMPELTSMH | TLFVREHNRL |
410 | 420 | 430 | 440 | 450 |
ATQLKRLNPR | WNGEKLYQEA | RKIVGAMVQI | ITYRDYLPLV | LGPAAMKKYL |
460 | 470 | 480 | 490 | 500 |
PQYRSYNDSV | DPRIANVFTN | AFRYGHTLIQ | PFMFRLNNQY | RPTGPNPRVP |
510 | 520 | 530 | 540 | 550 |
LSKVFFASWR | VVLEGGIDPI | LRGLMATPAK | LNRQNQIVVD | EIRERLFEQV |
560 | 570 | 580 | 590 | 600 |
MRIGLDLPAL | NMQRSRDHGL | PGYNAWRRFC | GLPQPSTVGE | LGTVLKNLEL |
610 | 620 | 630 | 640 | 650 |
ARKLMAQYGT | PNNIDIWMGG | VSEPLEPNGR | VGQLLACLIG | TQFRKLRDGD |
660 | 670 | 680 | 690 | 700 |
RFWWENPGVF | SKQQRQALAS | ISLPRIICDN | TGITTVSKNN | IFMSNTYPRD |
710 | 718 | |||
FVSCNTLPKL | NLTSWKET |
Data source: UniProt
Position of Targeted Peptide Analytes Relative to SNPs, Isoforms, and PTMs
Uniprot Database Entry PhosphoSitePlus ®
Click a point on a node
to view detailed assay information below
All other points link out to UniProt
Phosphorylation Acetylation Ubiquitylation Other
loading
Assay Details for CPTAC-6037 Collapse assay details
Data source: Panorama
Official Gene Symbol
MPO
Peptide Modified Sequence
IGLDLPALNM[+15.994915]QR
Modification Type
Oxidation (M)
Protein - Site of Modification
588
Peptide - Site of Modification
10
Peptide Start
579
Peptide End
590
CPTAC ID
CPTAC-6037
Peptide Molecular Mass
1,355.7231
Species
Human
Assay Type
Enrichment MRM
Enrichment Method
N/A
Matrix
FFPE lung tumor tissue lysate pool
Submitting Laboratory
Fred Hutchinson Cancer Research Center
Submitting Lab PI
Amanda Paulovich
Publication
View Details (opens in a new window)
Whiteaker JR, Zhao L, Schoenherr RM, Huang D, Lundeen RA, Voytovich U, Kennedy JJ, Ivey RG, Lin C, Murillo OD, Lorentzen TD, Colantonio S, Caceres TW, Roberts RR, Knotts JG, Reading JJ, Perry CD, Richardson CW, Garcia-Buntley SS, Bocik W, Hewitt SM, Chowdhury S, Vandermeer J, Smith SD, Gopal AK, Ramchurren N, Fling SP, Wang P, Paulovich AG. A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials. Front Oncol. 2023 May 2;13:1168710. doi: 10.3389/fonc.2023.1168710. PMID: 37205196; PMCID: PMC10185886.
Assay Parameters Collapse assay parameters
Data source: Panorama
Instrument
QTRAP 5500
Internal Standard
peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus R
LC
Eksigent nanoLC 425
Column Packing
3 µm ChromXP C18EP, 120 Å
Column Dimensions
150 x 0.075 mm
Flow Rate
0.3 µL/min
Chromatograms
Data source: Panorama
Response Curves
Data source: Panorama
Retrieving Data
Repeatability
Data source: Panorama
| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CV | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | b4 (1+) | 61 | 67.6 | 40.5 | 70.7 | 86.3 | 59.5 | 93.4 | 109.6 | 72 | 15 | 15 | 15 | | b5 (1+) | 41.8 | 60.7 | 58.9 | 69.1 | 59.7 | 75.7 | 80.8 | 85.1 | 95.9 | 15 | 15 | 15 | | y4 (1+) | 78.4 | 71.2 | 58.6 | 84.2 | 72.7 | 72.7 | 115 | 101.8 | 93.4 | 15 | 15 | 15 | | y6 (1+) | 72.4 | 70.4 | 53.7 | 79.1 | 87.5 | 76.1 | 107.2 | 112.3 | 93.1 | 15 | 15 | 15 | | y7 (1+) | 42.9 | 62.4 | 33.3 | 42.4 | 74.9 | 40.6 | 60.3 | 97.5 | 52.5 | 15 | 15 | 15 | | y8 (1+) | 48.6 | 68.8 | 31.2 | 45.1 | 67.7 | 74 | 66.3 | 96.5 | 80.3 | 15 | 15 | 15 | | y9 (1+) | 54 | 85.5 | 44.5 | 56.4 | 83.4 | 64.3 | 78.1 | 119.4 | 78.2 | 15 | 15 | 15 | | sum | 34.9 | 62 | 32.4 | 32 | 71.4 | 48.1 | 47.3 | 94.6 | 58 | 15 | 15 | 15 |
Additional Resources and Comments
Assay Details for CPTAC-6053 Collapse assay details
Data source: Panorama
Official Gene Symbol
MPO
Peptide Sequence
IGLDLPALNMQR
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
579
Peptide End
590
CPTAC ID
CPTAC-6053
Peptide Molecular Mass
1,339.7282
Species
Human
Assay Type
Enrichment MRM
Enrichment Method
N/A
Matrix
FFPE lung tumor tissue lysate pool
Submitting Laboratory
Fred Hutchinson Cancer Research Center
Submitting Lab PI
Amanda Paulovich
Publication
View Details (opens in a new window)
Whiteaker JR, Zhao L, Schoenherr RM, Huang D, Lundeen RA, Voytovich U, Kennedy JJ, Ivey RG, Lin C, Murillo OD, Lorentzen TD, Colantonio S, Caceres TW, Roberts RR, Knotts JG, Reading JJ, Perry CD, Richardson CW, Garcia-Buntley SS, Bocik W, Hewitt SM, Chowdhury S, Vandermeer J, Smith SD, Gopal AK, Ramchurren N, Fling SP, Wang P, Paulovich AG. A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials. Front Oncol. 2023 May 2;13:1168710. doi: 10.3389/fonc.2023.1168710. PMID: 37205196; PMCID: PMC10185886.
Assay Parameters Collapse assay parameters
Data source: Panorama
Instrument
QTRAP 5500
Internal Standard
peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus R
LC
Eksigent nanoLC 425
Column Packing
3 µm ChromXP C18EP, 120 Å
Column Dimensions
150 x 0.075 mm
Flow Rate
0.3 µL/min
Chromatograms
Data source: Panorama
Response Curves
Data source: Panorama
Retrieving Data
Repeatability
Data source: Panorama
| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CV | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | b5 (1+) | 20.5 | 20.8 | 19.8 | 18.4 | 22.7 | 23.4 | 27.5 | 30.8 | 30.7 | 15 | 15 | 15 | | y7 (1+) | 11 | 24.3 | 17.1 | 12.2 | 24.3 | 17.9 | 16.4 | 34.4 | 24.8 | 15 | 15 | 15 | | y8 (1+) | 9.3 | 22.3 | 20.4 | 16.2 | 26 | 27.3 | 18.7 | 34.3 | 34.1 | 15 | 15 | 15 | | y9 (1+) | 17.9 | 24.9 | 24.6 | 18.4 | 29 | 25.9 | 25.7 | 38.2 | 35.7 | 15 | 15 | 15 | | sum | 10.7 | 23.8 | 16.9 | 12 | 24.1 | 18 | 16.1 | 33.9 | 24.7 | 15 | 15 | 15 |
Additional Resources and Comments
Assay Details for non-CPTAC-3375 Collapse assay details
Data source: Panorama
Official Gene Symbol
Mpo
Peptide Sequence
IANVFTNAFR
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
464
Peptide End
473
CPTAC ID
non-CPTAC-3375
Peptide Molecular Mass
1,151.6087
Species
Mus musculus (Mouse)
Assay Type
Direct MRM
Matrix
Plasma
Submitting Laboratory
UVic-Genome BC Proteomics Centre
Submitting Lab PI
Christoph Borchers
Publication
View Details (opens in a new window)
Molecular phenotyping of laboratory mouse strains using 500 multiple reaction monitoring mass spectrometry plasma assays. Michaud SA, Sinclair NJ, Petrošová H, Palmer AL, Pistawka AJ, Zhang S, Hardie DB, Mohammed Y Eshghi A1, Richard VR, Sickmann A, Borchers CH. Commun Biol. 2018 Jun 27;1:78. doi: 10.1038/s42003-018-0087-6. eCollection 2018.
Assay Parameters Collapse assay parameters
Data source: Panorama
Instrument
Agilent 6490/6495 QQQ
Internal Standard
synthetic peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus R
LC
1290 LC (Agilent)
Column Packing
Zorbax Eclipse Plus C18, 1.8 µm
Column Dimensions
2.1 x 150 mm
Flow Rate
400 µL/min
Chromatograms
Data source: Panorama
Response Curves
Data source: Panorama
Retrieving Data
Repeatability
Data source: Panorama
| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CV | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | b4 (1+) | 11.9 | 6.6 | 3.9 | 19.1 | 10.3 | 4.9 | 22.5 | 12.2 | 6.3 | 15 | 15 | 15 | | b3 (1+) | 11.7 | 4 | 5.8 | 26.9 | 12.8 | 7.1 | 29.3 | 13.4 | 9.2 | 15 | 15 | 15 | | y5 (1+) | 3.5 | 6.5 | 6 | 13.7 | 11.3 | 6.8 | 14.1 | 13 | 9.1 | 15 | 15 | 15 | | y6 (1+) | 5.8 | 6.7 | 3.6 | 13.6 | 11.7 | 4.7 | 14.8 | 13.5 | 5.9 | 15 | 15 | 15 | | y8 (1+) | 5.5 | 5.2 | 5.7 | 13.3 | 7.9 | 6.2 | 14.4 | 9.5 | 8.4 | 15 | 15 | 15 | | sum | 2.6 | 3 | 1.5 | 14.4 | 9.5 | 3.8 | 14.6 | 10 | 4.1 | 15 | 15 | 15 |